Skip to main content
News Icon

News categories: Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

PD Dr. Niklas Klümper, Senior Physician in the Department of Urology at the University Hospital Bonn, was honored with the prestigious Johann-Georg-Zimmermann Research Prize on June 5, 2025. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions. This year, it was jointly awarded to PD Dr. Niklas Klümper and Prof. Dr. Elisabeth Hessmann from Göttingen.

Dr. Klümper leads a translational research group at the interface of urology and experimental oncology and is funded by the German Federal Ministry of Education and Research (BMBF) through the ACCENT program. His research aims to advance precision oncology by developing personalized therapies based on molecular markers. His award-winning work on NECTIN4 amplifications has already led to the initiation of several Phase II clinical trials with fast-track approval by the U.S. Food and Drug Administration (FDA)—a remarkable testament to the clinical relevance of his research.

His primary focus is in uro-oncology, particularly on the prediction and personalization of targeted therapies.

The official award ceremony took place at Hannover Medical School (MHH), where the prize was presented by MHH President Prof. Dr. Denise Hilfiker-Kleiner.

Source

UKB Campus News

Related news

Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Honors & Funding

Jörg Wenzel elected chair of EADV Task Force on Cutaneous Lupus Erythematosus (CLE)

The European Academy of Dermatology and Venereology (EADV) has establishment a new Task Force on Cutaneous Lupus Erythematosus (CLE), led by ImmunoSensation³ member Jörg Wenzel. CLE, as autoimmune disease of the skin, is a prime example of chronic inflammatory dysregulation, leading to a severe disease burden. The treatment of cutaneous lupus continues to face unresolved clinical challenges. The CLE Task Force is set up to push the boundaries of clinical care, update guidelines, and advance collaborative research across Europe.
EADV Task Forces
News Marvin Supercomputer

News categories: Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry

Back to the news overview